For this edition of the contest, a total of nine groundbreaking biomedical and health projects spearheaded by research institutions in Portugal were selected. Alongside CF, GIMM, and i3S, awards were also granted to projects from the Instituto de Tecnologia Química e Biológica António Xavier da Universidade Nova de Lisboa (ITQB NOVA), Instituto de Investigação em Ciências da Vida e da Saúde (ICVS) and Instituto de Biomedicina (iBiMED). These nine selected projects will receive more than €7.6 million in support.

Date and time:

18 November 2024 – 12:00

Location:

Champalimaud Foundation Auditorium

Description:

The Roles of AI in Scientific Discovery: Our Experience Studying Collective Behavio

Gonzalo de Polavieja (Mathematics of Behavior and Intelligence Lab)

Molecular Characterization of Cancer by Spatial Pathology

Mireia Castillo-Martin (Molecular and Experimental Pathology Lab)

Moderator: Ana Luísa Correia (Cancer Dormancy and Immunity Lab)

Host

Christa Rhiner, PhD, Stem Cells and Regeneration Lab

Venue

Seminar room

The Champalimaud Foundation's Breast Cancer Research Programme is made up of groups dedicated to all aspects related to the disease, from diagnosis to treatment. The goal is to improve the quality of life and survival of patients by utilising cutting-edge technologies that combine new techniques and methods with clinical practice to better serve patients.

In order for our bodies to efficiently transform into fat the excess carbohydrates we eat, in a process of  “lipogenesis”, two things  must happen. First, the immune system's gamma-delta T cells, a type of lymphocytes that are present in large quantities in adipose tissue (a.k.a. fat), have to produce a substance that triggers lipogenesis, called IL-17.

With nearly 30 presenters—including 4 keynote speakers—ranging from internationally renowned scientists to emerging researchers, the symposium was structured into eight thematic sessions, each exploring different dimensions, from the interplay between tumour cells and their microenvironment to the systemic impacts of cancer on the body.